MFST - Medifirst Solutions, Inc

Other OTC - Other OTC Delayed Price. Currency in USD
0.0164
+0.0013 (+8.61%)
At close: 2:53PM EDT
Stock chart is not supported by your current browser
Previous Close0.0151
Open0.0158
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0152 - 0.0164
52 Week Range0.0120 - 0.1500
Volume514,446
Avg. Volume843,755
Market Cap359,299
Beta (3Y Monthly)1.49
PE Ratio (TTM)N/A
EPS (TTM)-0.2860
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Medifirst Solutions Provides Company Update for Its Oral Mucositis Treatment Studies

    Freehold, NJ, Aug. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-810/2000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Premium Hemp and CBD products available at www.usacbdshopper.com, is pleased to provide a company update. Medifirst is pleased to announce that they are working with its affiliate and consulting groups in setting up a clinical trial for the treatment in reducing Oral Mucositis that will include three testing locations. Medifirst recently announced a new expansion and direction for its Time Machine Therapeutic Laser for the application of Photobiomodulation (PBM) to treat a side effect of cancer therapy called Oral Mucositis.

  • GlobeNewswire

    Medifirst Solutions Provides Company Update for Its Time Machine Laser and CBD Division

    Freehold, NJ, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Premium Hemp and CBD products, is pleased to provide a company update. Medifirst recently announced a possible new expansion and direction for its Time Machine Therapeutic Laser for the application of Photobiomodulation (PBM) to treat a side effect of cancer therapy called Oral Mucositis.  Medifirst is pleased to announce that they have engaged its FDA consulting firm to assist in preparing and submitting a pre-510(k) submission to the FDA for 510(k) indication for treating Oral Mucositis with its FDA 510(k) cleared hand-held Infrared 810nm Laser.

  • GlobeNewswire

    Medifirst Solutions Company Update

    Freehold, NJ, July 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Premium Hemp and CBD products, is pleased to provide a company update. Medifirst Solutions previously announced that they have been approved for credit card processing for its USA Premium CBD & Hemp products division.

  • PC Shipments Bounce Back in Q2: LNVGY, HPQ & More in View
    Zacks

    PC Shipments Bounce Back in Q2: LNVGY, HPQ & More in View

    Here's a sneak peek of the worldwide PC market performance in the second quarter of 2019, per IDC and Gartner report.

  • GlobeNewswire

    Medifirst Solutions Gets Approval for Merchant Account for Hemp and CBD Products

    Freehold, NJ, June 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Premium Hemp and CBD products, is pleased to provide an update. Medifirst Solutions is pleased to announce that they have been approved for credit card processing for its USA CBD & Hemp products division. The CBD and Hemp products includes a 500mg oil, 1000mg oil and a premium 6000mg oil.

  • GlobeNewswire

    Medifirst Solutions Completes Time Machine Laser Sales for Two New Markets

    Freehold, NJ, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Pharma CBD, is pleased to provide a laser sales update. Medifirst Solutions is pleased to announce that a high school in Nebraska has successfully completed a test trial using the Time Machine Therapeutic Laser for sports related injuries.

  • PC Shipments Soften in Q1: LNVGY, HPQ, DELL & AAPL in View
    Zacks

    PC Shipments Soften in Q1: LNVGY, HPQ, DELL & AAPL in View

    Let's take a look at how the leading PC vendors are performing in the market, which ceaselessly demonstrates a downtrend.

  • GlobeNewswire

    Medifirst Solutions Completes Distribution Agreement

    Freehold, NJ, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of Dr. Gupta Pharma CBD, is pleased to provide a distribution update. Regarding international distribution, Medifirst recently announced it is in the final stages of negotiation with a distribution company for distribution rights for its Infrared Laser for Latin America.

  • GlobeNewswire

    Medifirst Solutions Provides a Company Update

    As previously announced, Medifirst has been working with Antah HealthCare Group to introduce and test the FDA cleared therapeutic Time Machine Infrared Laser as a drug-free and all natural treatment for pain and inflammation. Commented Medifirst President, Bruce J. Schoengood, “We are very pleased to announce that after successfully testing and purchasing the Time Machine Laser, Antah has agreed to become a distributor for Medifirst.

  • GlobeNewswire

    Medifirst Solutions Applauds the Passage of the Farm Bill at the American Pain Association Symposium in Philadelphia

    Freehold, NJ, Dec. 17, 2018 -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”): Speaking at the American Pain Association (APA).

  • GlobeNewswire

    Medifirst Solutions to Present at the American Pain Association Conferences Focusing on Medical CBD and the Opioid Epidemic

    Freehold, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services, is pleased to announce that Dr. Sanjay Gupta, President of the American Pain Association (APA), is sponsoring a symposium, called “Turn the Tide,” addressing the opioid epidemic.  The first symposium will be held on Wednesday, December 12th, at the Philadelphia College of Osteopathic Medicine (PCOM). Medifirst, through its majority owned subsidiary USA Pharma Inc., is working with Dr. Gupta and APA to explore and develop solutions on how Medical CBD can help in this growing crisis.

  • GlobeNewswire

    Medifirst Solutions Finalizes Relationship With Dr. Gupta Pharma

    Freehold, NJ, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services, is pleased to introduce Dr. Sanjay Gupta, Chief Executive Officer of Dr. Gupta Pharma LLC and President of the American Pain Association, as the Company’s partner in its new Cannabidiol (“CBD”) division. Medifirst recently announced that it has launched USA Pharma, Inc., its division for CBD distribution, sales and products and that it completed an agreement with Dr. Gupta Pharma LLC to distribute a line of premium CBD oils.

  • GlobeNewswire

    Medifirst Solutions Announces New Agreement for CBD Products and Distribution

    Freehold, NJ, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services, is pleased to announce an update regarding its new cannabidiol (“CBD”) division. Medifirst is pleased to announce that it has launched a majority-owned subsidiary USA Pharma, Inc., a division for its CBD distribution, sales and products. Medifirst is also pleased to announce it has completed an agreement with Dr. Gupta Pharma LLC to distribute a line of premium CBD oils.